Selective activation of estrogen receptor-βtarget genes by 3,3′-diindolylmethane

Endocrinology

Volumn 151, Issue 4, 2010, Pages 1662-1667

  Vivar, Omar I ^a,b   Saunier, Elise F ^b   Leitman, Dale C ^a,b   Firestone, Gary L ^a   Bjeldanes, Leonard F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,3' DIINDOLYLMETHANE; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LUCIFERASE; NUCLEAR RECEPTOR COACTIVATOR 2;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENE ACTIVATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REPORTER GENE; TRANSCRIPTION INITIATION;

CELL LINE; CELLS, CULTURED; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GENE SILENCING; GENES, REPORTER; HUMANS; INDOLES; NUCLEAR RECEPTOR COACTIVATOR 2; ORGANOPLATINUM COMPOUNDS; RADIOLIGAND ASSAY; RESPONSE ELEMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSFECTION;

EID: 77950252757     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-1028     Document Type: Article

References (39)

1. Chambon P 2005 The nuclear receptor superfamily: a personal retrospect on the first two decades. Mol Endocrinol 19:1418-1428
2. Koehler KF, Helguero LA, Haldosén LA, Warner M, Gustafsson JA 2005 Reflections on the discovery and significance of estrogen receptor β. Endocr Rev 26:465-478
3. Kian Tee M, Rogatsky I, Tzagarakis-Foster C, Cvoro A, An J, Christy RJ, Yamamoto KR, Leitman DC 2004 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors α and β. Mol Biol Cell 15:1262-1272
4. Hewitt SC, Harrell JC, Korach KS 2005 Lessons in estrogen biology from knockout and transgenic animals. Annu Rev Physiol 67:285-308
5. Harris HA 2007 Estrogen receptor-β: recent lessons from in vivo studies. Mol Endocrinol 21:1-13
6. Förster C, Mäkela S, Wärri A, Kietz S, Becker D, Hultenby K, Warner M, Gustafsson JA 2002 Involvement of estrogen receptor β in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 99:15578-15583
7. Shim GJ, Wang L, Andersson S, Nagy N, Kis LL, Zhang Q, Mäkelä S, Warner M, Gustafsson JA 2003 Disruption of the estrogen receptor β gene in mice causes myeloproliferative disease resembling chronic myeloid leukemia with lymphoid blast crisis. Proc Natl Acad Sci USA 100:6694-6699
8. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, SmithiesO1998 Generation and reproductive phenotypes of mice lacking estrogen receptor β. Proc Natl Acad Sci USA 95:15677-15682
9. Imwalle DB, Gustafsson JA, Rissman EF 2005 Lack of functional estrogen receptor β influences anxiety behavior and serotonin content in female mice. Physiol Behav 84:157-163
10. Rissman EF, Heck AL, Leonard JE, Shupnik MA, Gustafsson JA 2002 Disruption of estrogen receptor β gene impairs spatial learning in female mice. Proc Natl Acad Sci USA 99:3996-4001
11. Rocha BA, Fleischer R, Schaeffer JM, Rohrer SP, Hickey GJ 2005 17 β-Estradiol-induced antidepressant-like effect in the forced swim test is absent in estrogen receptor-β knockout (BERKO) mice. Psychopharmacology (Berl) 179:637-643
12. Grose KR, Bjeldanes LF 1992 Oligomerization of indole-3-carbinol in aqueous acid. Chem Res Toxicol 5:188-193
13. Staub RE, Feng C, Onisko B, Bailey GS, Firestone GL, Bjeldanes LF 2002 Fate of indole-3-carbinol in cultured human breast tumor cells. Chem Res Toxicol 15:101-109
14. Auborn KJ 2002 Therapy for recurrent respiratory papillomatosis. Antivir Ther 7:1-9
15. Wiatrak BJ 2003 Overview of recurrent respiratory papillomatosis. Curr Opin Otolaryngol Head Neck Surg 11:433-441
16. Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL, Bjeldanes LF 2004 Pilot study: effect of 3,3′-diindolylmethane supplements on urinary hormone metabolites in postmenopausal women with a history of early-stage breast cancer. Nutr Cancer 50:161-167
17. Kabat GC, O'Leary ES, Gammon MD, Sepkovic DW, Teitelbaum SL, Britton JA, Terry MB, Neugut AI, Bradlow HL 2006 Estrogen metabolism and breast cancer. Epidemiology 17:80-88
18. Chang X, Tou JC, Hong C, Kim HA, Riby JE, Firestone GL, Bjeldanes LF 2005 3,3′-Diindolylmethane inhibits angiogenesis and the growth of transplantable human breast carcinoma in athymic mice. Carcinogenesis 26:771-778
19. 1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/ CIP1) expression. Carcinogenesis 23:1297-1305
20. 1 arrest in human prostate cancer cells irrespective of androgen receptor and p53 status. Biochem Pharmacol 78:469-476
21. Leong H, Riby JE, Firestone GL, Bjeldanes LF 2004 Potent ligand-independent estrogen receptor activation by 3,3′-diindolylmethane is mediated by cross talk between the protein kinase A and mitogenactivated protein kinase signaling pathways. Mol Endocrinol 18: 291-302
22. Cvoro A, Paruthiyil S, Jones JO, Tzagarakis-Foster C, Clegg NJ, Tatomer D, Medina RT, Tagliaferri M, Schaufele F, Scanlan TS, Diamond MI, Cohen I, Leitman DC 2007 Selective activation of estrogen receptor-β transcriptional pathways by an herbal extract. Endocrinology 148:538-547
23. Cvoro A, Tatomer D, Tee MK, Zogovic T, Harris HA, Leitman DC 2008 Selective estrogen receptor-β agonists repress transcription of proinflammatory genes. J Immunol 180:630-636
24. An J, Tzagarakis-Foster C, Scharschmidt TC, Lomri N, Leitman DC 2001 Estrogen receptor β-selective transcriptional activity and recruitment of coregulators by phytoestrogens. J Biol Chem 276:17808-17814
25. Levy N, Zhao X, Tang H, Jaffe RB, Speed TP, Leitman DC 2007 Multiple transcription factor elements collaborate with estrogen receptor α to activate an inducible estrogen response element in the NKG2E gene. Endocrinology 148:3449-3458
26. Levy N, Paruthiyil S, Zhao X, Vivar OI, Saunier EF, Griffin C, Tagliaferri M, Cohen I, Speed TP, Leitman DC 8 September 2009 Unliganded estrogen receptor-β regulation of genes is inhibited by tamoxifen. Mol Cell Endocrinol 10.1016/j.mce.2009.08.030
27. Burakov D, Crofts LA, Chang CP, Freedman LP 2002 Reciprocal recruitment of DRIP/mediator and p160 coactivator complexes in vivo by estrogen receptor. J Biol Chem 277:14359-14362
28. Levy N, Tatomer D, Herber CB, Zhao X, Tang H, Sargeant T, Ball LJ, Summers J, Speed TP, Leitman DC 2008 Differential regulation of native estrogen receptor-regulatory elements by estradiol, tamoxifen, and raloxifene. Mol Endocrinol 22:287-303
29. Barkhem T, Carlsson B, Nilsson Y, Enmark E, Gustafsson J, Nilsson S 1998 Differential response of estrogen receptor α and estrogen receptor β to partial estrogen agonists/antagonists. Mol Pharmacol 54:105-112
30. Choi I, Gudas LJ, Katzenellenbogen BS 2000 Regulation of keratin 19 gene expression by estrogen in human breast cancer cells and identification of the estrogen responsive gene region. Mol Cell Endocrinol 164:225-237
31. Cvoro A, Tzagarakis-Foster C, Tatomer D, Paruthiyil S, Fox MS, Leitman DC 2006 Distinct roles of unliganded and liganded estrogen receptors in transcriptional repression. Mol Cell 21:555-564
32. Mersereau JE, Levy N, Staub RE, Baggett S, Zogovic T, Chow S, Ricke WA, Tagliaferri M, Cohen I, Bjeldanes LF, Leitman DC2008 Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist. Mol Cell Endocrinol 283:49-57
33. Le HT, Schaldach CM, Firestone GL, Bjeldanes LF 2003 Plant-derived 3,3′-diindolylmethane is a strong androgen antagonist in human prostate cancer cells. J Biol Chem 278:21136-21145
34. Xue L, Firestone GL, Bjeldanes LF 2005 DIM stimulates IFNγ gene expression in human breast cancer cells via the specific activation of JNK and p38 pathways. Oncogene 24:2343-2353
35. Zhao C, Dahlman-Wright K, Gustafsson JA 2008 Estrogen receptor β: an overview and update. Nucl Recept Signal 6:e003
36. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, Burow ME 2006 p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol 20:971-983
37. Krum SA, Miranda-Carboni GA, Lupien M, Eeckhoute J, Carroll JS, Brown M 2008 UniqueERα cistromes control cell type-specific gene regulation. Mol Endocrinol 22:2393-2406
38. Harris HA, Albert LM, Leathurby Y, Malamas MS, Mewshaw RE, Miller CP, Kharode YP, Marzolf J, Komm BS, Winneker RC, Frail DE, Henderson RA, Zhu Y, Keith Jr JC 2003 Evaluation of an estrogen receptor-β agonist in animal models of human disease. Endocrinology 144:4241-4249
39. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, Katzenellenbogen JA 2001 Estrogen receptor-β potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251